Literature DB >> 33363535

Methods to Detect MHC-Specific IgE in Mice and Men.

Anna Marianne Weijler1, Jasmin Mucha1, Andreas Michael Farkas1, Ulrike Baranyi2, Nina Pilat1, Ara Cho1,3, Moritz Muckenhuber1, Stefan Hopf1, Markus Wahrmann4, Birgit Linhart5, Rudolf Valenta5,6,7,8, Thomas Wekerle1.   

Abstract

Humoral immunity is a major barrier limiting long-term outcome after organ transplantation. Especially, the production of antibodies directed against donor HLA/MHC antigens (i.e. donor-specific antibodies (DSA)) leading to antibody-mediated rejection (ABMR) is considered to be a major factor negatively affecting allograft survival. DSAs of the IgG isotype are routinely measured in transplant patients. However, not all patients diagnosed with IgG-DSA develop ABMR events. Therefore, research in better understanding the mechanisms of ABMR is of great importance. We recently demonstrated the production of MHC-specific IgE upon allograft rejection in mice and in transplant patients. IgE is classically connected with allergy and is known to be important for the humoral defense against helminths and worms. However, its role in autoimmune diseases and cancer has been reported recently as well. The concentration of IgE in blood is extremely low compared to other antibody isotypes. Therefore, detection of MHC-specific IgE from serum requires methods of high sensitivity. Since MHC-specific IgG-typically present at much higher serum levels-develops as well, high specificity is also required of IgE detection methods. In the murine model we developed an enzyme linked immunosorbent assay (ELISA) using MHC monomers for measurement of MHC-specific IgE, allowing us to distinguish between specificities of antibodies against different class I and class II antigens. For measurement of functional activity of MHC-specific IgE in vitro, a release assay using a rat basophil cell line (RBL-2H3) was established. For functional analysis of MHC-specific IgE in vivo, a cutaneous hypersensitivity reaction assay was adapted for this purpose using MHC monomers. Humanized RBL-2H3 cells transfected with cDNA coding for the human-high affinity IgE receptor were used for functionality measurement of donor-specific IgE in sensitized transplant patients. For detection of HLA-specific IgE, a bead assay was adapted, using beads expressing single HLA antigens. The aim of this publication is to demonstrate currently established methods for the detection and characterization of MHC-specific IgE in the murine and human setting.
Copyright © 2020 Weijler, Mucha, Farkas, Baranyi, Pilat, Cho, Muckenhuber, Hopf, Wahrmann, Linhart, Valenta and Wekerle.

Entities:  

Keywords:  HLA; IgE; MHC; antibody-mediated rejection; donor specific antibodies; transplantation

Year:  2020        PMID: 33363535      PMCID: PMC7753192          DOI: 10.3389/fimmu.2020.586856

Source DB:  PubMed          Journal:  Front Immunol        ISSN: 1664-3224            Impact factor:   7.561


  50 in total

1.  Complement Interference Is Not the Same as a Prozone Phenomenon.

Authors:  M Berth
Journal:  Am J Transplant       Date:  2016-02-17       Impact factor: 8.086

2.  Absence of recipient CCR5 promotes early and increased allospecific antibody responses to cardiac allografts.

Authors:  Hiroyuki Amano; Alice Bickerstaff; Charles G Orosz; Andrew C Novick; Hiroshi Toma; Robert L Fairchild
Journal:  J Immunol       Date:  2005-05-15       Impact factor: 5.422

3.  Antibody-mediated rejection of cardiac allografts in CCR5-deficient recipients.

Authors:  Taiji Nozaki; Hiroyuki Amano; Alice Bickerstaff; Charles G Orosz; Andrew C Novick; Kazunari Tanabe; Robert L Fairchild
Journal:  J Immunol       Date:  2007-10-15       Impact factor: 5.422

4.  The second international reference preparation for human serum immunoglobulin E and the first British standard for human serum immunoglobulin E.

Authors:  V Seagroatt; S G Anderson
Journal:  J Biol Stand       Date:  1981-10

Review 5.  Use of a rat basophil leukemia (RBL) cell-based immunological assay for allergen identification, clinical diagnosis of allergy, and identification of anti-allergy agents for use in immunotherapy.

Authors:  Na Sun; Cui Zhou; Xin Zhou; Lu Sun; Huilian Che
Journal:  J Immunotoxicol       Date:  2014-06-12       Impact factor: 3.000

Review 6.  Detection of alloantibody-mediated complement activation: A diagnostic advance in monitoring kidney transplant rejection?

Authors:  Georg A Böhmig; Zeljko Kikic; Markus Wahrmann; Farsad Eskandary; Arezu Z Aliabadi; Gerhard J Zlabinger; Heinz Regele; Helmut E Feucht
Journal:  Clin Biochem       Date:  2015-06-26       Impact factor: 3.281

Review 7.  Strategies for long-term preservation of kidney graft function.

Authors:  Thomas Wekerle; Dorry Segev; Robert Lechler; Rainer Oberbauer
Journal:  Lancet       Date:  2017-05-27       Impact factor: 79.321

8.  Mast cell degranulation breaks peripheral tolerance.

Authors:  V C de Vries; A Wasiuk; K A Bennett; M J Benson; R Elgueta; T J Waldschmidt; R J Noelle
Journal:  Am J Transplant       Date:  2009-07-22       Impact factor: 8.086

Review 9.  Unraveling the Role of Allo-Antibodies and Transplant Injury.

Authors:  Yoshiko Matsuda; Minnie M Sarwal
Journal:  Front Immunol       Date:  2016-10-21       Impact factor: 7.561

10.  Epithelial damage and tissue γδ T cells promote a unique tumor-protective IgE response.

Authors:  Greg Crawford; Mark David Hayes; Rocio Castro Seoane; Sophie Ward; Tim Dalessandri; Chester Lai; Eugene Healy; David Kipling; Charlotte Proby; Colin Moyes; Kile Green; Katie Best; Muzlifah Haniffa; Marina Botto; Deborah Dunn-Walters; Jessica Strid
Journal:  Nat Immunol       Date:  2018-07-16       Impact factor: 25.606

View more
  2 in total

1.  Impact of Graft-Resident Leucocytes on Treg Mediated Skin Graft Survival.

Authors:  Romy Steiner; Anna M Weijler; Thomas Wekerle; Jonathan Sprent; Nina Pilat
Journal:  Front Immunol       Date:  2021-11-29       Impact factor: 7.561

2.  Preventive Administration of Non-Allergenic Bet v 1 Peptides Reduces Allergic Sensitization to Major Birch Pollen Allergen, Bet v 1.

Authors:  Oluwatoyin Akinfenwa; Huey-Jy Huang; Birgit Linhart; Margarete Focke-Tejkl; Susanne Vrtala; Alina Poroshina; Alexandra Nikonova; Musa Khaitov; Nicholas J Campion; Julia Eckl-Dorna; Verena Niederberger-Leppin; Bernhard Kratzer; Peter Anton Tauber; Winfried F Pickl; Michael Kundi; Raffaela Campana; Rudolf Valenta
Journal:  Front Immunol       Date:  2021-10-26       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.